
Imagine a silent health crisis affecting over one-third of adults worldwide, creeping into the lives of millions without noticeable symptoms until it’s too late, and posing a severe threat to both liver and heart health. Metabolic dysfunction-associated steatotic liver disease, commonly known as
I'm thrilled to sit down with Ivan Kairatov, a renowned biopharma expert whose extensive experience in research and development, combined with a deep understanding of technology and innovation, has positioned him as a leading voice in the industry. Today, we'll dive into the transformative role of
Imagine a world where a cancer diagnosis no longer carries the weight of despair, but instead offers a pathway to tailored, effective treatment. In 2025, this vision is closer than ever, as groundbreaking advancements in cancer research reshape how the disease is prevented, detected, and treated.
In a landscape where millions of patients with advanced chronic kidney disease (CKD) struggle with limited and often burdensome treatment options, a groundbreaking development has emerged to potentially transform their lives. Opterion Health AG, a clinical-stage biopharmaceutical company
What if a single policy change could jeopardize decades of progress in safeguarding children from a silent, deadly virus, and what would be the consequences of such a shift? The debate over delaying the hepatitis B vaccine from birth to age 4 has erupted into a heated controversy, pitting public
In a groundbreaking stride toward health equity, a pair of visionary sisters has introduced an innovative solution to address the longstanding disparities in healthcare for Black women, marking a significant milestone in medical accessibility. Dr. Jacqueline Philips and Lorraine Phillips have
What if a simple eye scan could forecast a patient’s risk of losing vision to a stealthy, progressive condition long before irreversible damage sets in, offering a lifeline to preserve sight? This question is no longer a distant dream but a tangible reality emerging in the field of ophthalmology.
The relentless battle against cancer continues to drive scientific innovation, with researchers exploring every possible avenue to develop treatments that can effectively target cancer cells while sparing healthy tissues from harm. One particularly promising approach involves anticancer peptides
In an era where robotics and artificial intelligence (AI) are transforming industries at an unprecedented pace, staying informed about the latest breakthroughs and trends is more crucial than ever. Imagine a world where autonomous systems seamlessly integrate into daily life, from manufacturing
I'm thrilled to sit down with Ivan Kairatov, a renowned biopharma expert with extensive experience in research and development, and a deep understanding of technology and innovation in the industry. Today, we’re diving into the groundbreaking world of AI-driven drug discovery, focusing on a
ITCurated uses cookies to personalize your experience on our website. By continuing to use this site, you agree to our Cookie Policy